Industry Insights: From rare disease to chronic indications, cell and gene therapies broaden their impact
Year: 2026
Type: article
Abstract: Abi Pinchbeck, Commissioning Editor, Cell & Gene Therapy InsightsAs a commissioning editor with extensive experience in advanced therapy journal publishing, Abi’s focus is on progressing the field by facilitating and disseminating high-impact, open access content covering novel and existing cell and gene therapies. Abi works closely with academic scientists and industry professionals to publish cutting-edge original research, expert reviews, and multimedia content with a translational and interdisciplinary focus. Abi’s key aim is to explore the latest advances in cell and gene therapy R&D, clinical development, manufacturing, and commercialization. In addition to Abi’s editorial responsibilities, she maintains a strong network of experts across the biotech and pharma industries, staying up to date with emerging trends and breakthroughs in advanced therapies.
Source: Cell and Gene Therapy Insights
Author: Abigail Pinchbeck
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W7125797223
FWCI:
Cites:
Cited by:
Related to: